Case Study: OpGen, Inc.

LSG advised OpGen on its transformative capital raise from highly-regarded institutional investors.

• OpGen’s technology provides rapid identification of bacterial pathogens without culturing
• LSG’s extensive early discussions with Company re corporate strategy led to an improved corporate focus
• Parallel path proposed by LSG with corporate partners and institutional investors provided valuable strategic and operational insights
• LSG identified investors and negotiated a successful $23.6 million transaction on behalf of the Company
• Four well-established investors- CHL, Highland, Versant and In-Q-Tel – joined existing investors in the financing